# Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

> **NCT02058251** · PHASE1 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 73 (actual)

## Conditions studied

- Alcohol Use Disorders

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02058251
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-01
- **Final completion:** 2017-04
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02058251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02058251, "Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02058251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*